Clinical trials sponsored by Oswaldo Cruz Foundation
5
Recruiting trials
7
Conditions studied
Phase breakdown
Phase 4 1Not applicable 4
Conditions studied
| Condition | Trials |
|---|---|
| HIV | 5 |
| HIV Infections | 4 |
| Chlamydia Infections | 1 |
| Contact With or Exposure to Human Immunodeficiency Virus | 1 |
| Gonorrhea | 1 |
| Sexually Transmitted Diseases | 1 |
| Syphilis | 1 |
Recruiting trials led by Oswaldo Cruz Foundation
- Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
- ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
- Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
- Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro
- Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence
Common questions
How many trials is Oswaldo Cruz Foundation recruiting for?
Oswaldo Cruz Foundation is the lead sponsor of 5 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.